prevent cancer relapse, metastasis


 The Democratic People's Republic of Korea (DPRK) developed an efficacious vaccine to prevent relapse and metastasis of cancer, the official news agency KCNA reported on Thursday.

The vaccine had been developed to prevent liver, lung, stomach and other cancers from relapse and metastasis after operation, said its developer Ri Il Hun, a section chief of the Tumor Institute under the Academy of Medical Science.

"According to nearly 10 years of animal experiments, its cancer growth suppression rate is as high as 68.8 percent," he said.

Ri added that the clinical examinations of some 600 patients operated for liver, lung and stomach cancers show that the efficacy of the vaccine is 54 percent, 32.8 percent and 20.3 percent higher than other medicines in five-year survival rate.
hezuohuoban tianhuangdilao

posted by aa86 in:
Find quality Products, Trade Leads,
Manufacturers, Suppliers, Buyers and Wholesalers. Free Trade Blog